Sagimet Biosciences Inc (NASDAQ:SGMT) shares, rose in value on Thursday, April 16, with the stock price up by 9.41% to the previous day’s close as strong demand from buyers drove the stock to $2.21.
Actively observing the price movement in the last trading, the stock closed the session at $2.02, falling within a range of $2.02 and $2.22. Referring to stock’s 52-week performance, its high was $7.38, and the low was $1.73. On the whole, SGMT has fluctuated by -42.60% over the past month.
With the market capitalization of Sagimet Biosciences Inc currently standing at about $67.79 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-11.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that SGMT’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the price of SGMT currently trading nearly -20.66% and -36.33% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 35.34, while the 7-day volatility ratio is showing 8.72% which for the 30-day chart, stands at 10.50%. Furthermore, Sagimet Biosciences Inc (SGMT)’s beta value is 2.81, and its average true range (ATR) is 0.28.
A comparison of Sagimet Biosciences Inc (SGMT) with its peers suggests the former has fared considerably weaker in the market. SGMT showed an intraday change of 9.41% in last session, and over the past year, it shrunk by -47.13%%.
Data on historical trading for Sagimet Biosciences Inc (NASDAQ:SGMT) indicates that the trading volumes over the past 10 days have averaged 0.61 and over the past 3 months, they’ve averaged 639.12K. According to company’s latest data on outstanding shares, there are 30.67 million shares outstanding.
Nearly 27.72% of Sagimet Biosciences Inc’s shares belong to company insiders and institutional investors own 41.64% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 3.96 million shares as on 2025-03-31, resulting in a short ratio of 12.01. According to the data, the short interest in Sagimet Biosciences Inc (SGMT) stood at 1467.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 4.98 million. The stock has fallen by -50.89% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the SGMT stock heading into the next quarter.
